Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    N Nitrosodiethylamine

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Contaminated diabetes drugs raise red flag for FDA oversight
    Contaminated diabetes drugs raise red flag for FDA oversight

    28 May 2020

    // Jacob Bell BIOPHARMADIVE

    https://www.biopharmadive.com/news/fda-metformin-ndma-contamination/578771/

    Jacob Bell BIOPHARMADIVE
    28 May 2020
    Share Share
    FDA Alerts Patients and Health Professionals to Nitrosamine Impurity Metformin
    FDA Alerts Patients and Health Professionals to Nitrosamine Impurity Metformin

    28 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/fda-alerts-patients-and-health-care-professionals-to-nitrosamine-impurity-findings-in-certain-metformin-extended-release-products-301067454.html

    PRNEWSWIRE
    28 May 2020
    Share Share
    FDA Seeks Withdrawal of Heartburn Drugs Due to New Carcinogen Concerns
    FDA Seeks Withdrawal of Heartburn Drugs Due to New Carcinogen Concerns

    02 Apr 2020

    // Z. Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2020/4/fda-seeks-withdrawal-of-heartburn-drugs-due-to-new

    Z. Brennan RAPS
    02 Apr 2020
    Share Share
    Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine
    Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine

    18 Dec 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/glenmark-pharmaceuticals-inc-usa-voluntarily-recalls-all-unexpired-lots-of-its-ranitidine-1576662691.pdf

    FDA
    18 Dec 2019
    Share Share
    FDA warns of carcinogen found in diabetes drugs outside of US
    FDA warns of carcinogen found in diabetes drugs outside of US

    11 Dec 2019

    // Amy Lieu FOX10

    https://www.fox10phoenix.com/news/fda-warns-of-carcinogen-found-in-diabetes-drugs-outside-of-us

    Amy Lieu FOX10
    11 Dec 2019
    Share Share
    NDMA investigation leads to cases discovered in diabetes treatment
    NDMA investigation leads to cases discovered in diabetes treatment

    10 Dec 2019

    // Ben Hargreaves IN-PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2019/12/09/Impurities-discovered-in-metformin

    Ben Hargreaves IN-PHARMATECHNOLOGIST
    10 Dec 2019
    Share Share